{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.205B vs. cons $1.198B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.96 vs. cons $3.92",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "CAG diagnostics recurring revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$966M vs. cons $962.9M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 revenue",
      "prediction": "UNCHANGED",
      "answer": "guide $4.675B-$4.760B vs. cons $4.705B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 operating EPS",
      "prediction": "UNCHANGED",
      "answer": "guide $14.45-$14.90 vs. cons $14.66",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 revenue",
      "prediction": "UNCHANGED",
      "answer": "guide midpoint ~$1.20B vs. cons $1.191B",
      "confidence": "LOW"
    },
    {
      "kpi": "Q3 operating EPS",
      "prediction": "UNCHANGED",
      "answer": "guide midpoint ~$3.76 vs. cons $3.76",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 maintained FY outlook leaves estimates flat and exposes the premium multiple",
  "day5_confidence": "LOW"
}